Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in AVXL — Anavex Life Sciences Corp.

CIK 72971 SAN FRANCISCO, CA
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$302,184
+$58,289 QoQ
Shares Held
116,674
+46.9% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. AVXL ranks #219 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in AVXL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $302,184 116,674
2026-03-31 $243,895 79,445
2025-12-31 $476,397 133,820
2025-09-30 $1,013,442 113,870
2025-06-30 $952,369 103,294
2025-03-31 $853,459 99,471
2024-12-31 $1,089,819 101,473
2024-09-30 $742,908 130,794
2024-06-30 $356,011 84,363
2024-03-31 $371,192 72,926
2023-12-31 $634,438 68,146
2023-09-30 $731,509 111,681
2023-06-30 $1,273,888 156,690
2023-03-31 $1,367,582 159,578
2022-12-31 $834,908 90,163
2022-09-30 $381,385 36,956
2022-06-30 $370,369 37,000
2022-03-31 $1,330,082 108,049
2021-12-31 $2,213,536 127,655
2021-09-30 $1,754,431 97,740
2021-06-30 $2,077,994 90,901
2021-03-31 $856,394 57,284
2020-12-31 $788,361 145,993
2020-09-30 $688,851 151,396
2020-06-30 $780,537 158,646
2020-03-31 $388,791 123,426